On May 3, 2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Alpern's direct holdings in the company increased to a total of 34,443 shares. The grant, which is part of a standard company award or acquisition process, was completed on the same day. The shares acquired have a par value of $0.01 each, and the transaction was conducted in USD. This event could indicate the company's ongoing investment in its leadership team, potentially affecting investor sentiment.

On May 3, 2024, Robert J Alpern, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Alpern's direct holdings in the company increased to a total of 34,443 shares. The grant, which is part of a standard company award or acquisition process, was completed on the same day. The shares acquired have a par value of $0.01 each, and the transaction was conducted in USD. This event could indicate the company's ongoing investment in its leadership team, potentially affecting investor sentiment.